IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Eversept Partners, LP

Q4 2023 Holdings

Filed 2024-02-14 | 57 holdings | $1.1B | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Spdr S&P 500 ETF TR(SPY)PutTR UNIT78462F103$57.0M120,0005.0%
Invesco QQQ TR(QQQ)PutUNIT SER 146090E103$61.4M150,0005.4%
Teva Pharmaceutical Inds LTD(TEVA)SPONSORED ADS881624209$64.3M6,154,3545.6%
Inspire MED SYS Inc(INSP)COM457730109$71.4M351,1166.3%
Syndax Pharmaceuticals Inc(SNDX)COM87164F105$73.1M3,383,2446.4%
GSK PLC(GSK)SPONSORED ADR37733W204$110.2M2,972,9549.7%
Natera Inc(NTRA)COM632307104$141.0M2,251,58812.4%
PreviousPage 2 of 2